ClinicalTrials.govpublic full text
Study of Tislelizumab in Participants With Resectable Esophageal Squamous Cell Carcinoma
resectable esophageal squamous cell carcinoma, tislelizumab, pet, chemotherapy, chemoradiotherapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 980538
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.